Discover
SLDB
Solid Biosciences Inc.
8.46
3 x 8.00
1 x 8.50
bid
ask
+
0.00
0.00%
1 @ 04:00 PM
8.49 +0.03 (0.35%)
| Ytd | 50.00% | |
| 1y | 35.79% |
day range
3.79
52 week range
11.45
| Open | Prev Close | 8.46 | Low | High | Mkt Cap | 659.12M | |||
| Vol | 0.00 | Avg Vol | 1.69M | EPS | -1.92 | P/E | -4.41 | Forward P/E | -5.69 |
| Beta | 2.36 | Short Ratio | 9.40 | Inst. Own | 104.56% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 8.14 | 200-d Avg | 6.71 | 1yr Est | 17.38 |
| Income Statement | |||
| Operating Expenses | 57.31M | ||
| Research and Development Expense | 46.14M | ||
| Selling, General and Administrative Expense | 11.17M | ||
| Operating Income | -57.31M | ||
| Net Income | -56.74M | ||
| Net Income Common Stock | -56.74M | ||
| Net Income Common Stock (USD) | -56.74M | ||
| Consolidated Income | -56.74M | ||
| Earnings per Basic Share | -0.52 | ||
| Earnings per Basic Share (USD) | -0.52 | ||
| Earnings per Diluted Share | -0.52 | ||
| Earning Before Interest & Taxes (EBIT) | -56.74M | ||
| Earning Before Interest & Taxes (USD) | -56.74M | ||
| Weighted Average Shares | 109.81M | ||
| Weighted Average Shares Diluted | 109.81M | ||
| Balance Sheet | |||
| Cash and Equivalents | 297.74M | ||
| Cash and Equivalents (USD) | 297.74M | ||
| Investments | 84.29M | ||
| Investments Current | 83.58M | ||
| Investments Non-Current | 708.00K | ||
| Current Assets | 396.79M | ||
| Property, Plant & Equipment Net | 25.21M | ||
| Total Assets | 422.89M | ||
| Debt Current | 2.19M | ||
| Total Debt | 20.67M | ||
| Current Liabilities | 30.28M | ||
| Debt Non-Current | 18.48M | ||
| Total Liabilities | 48.76M | ||
| Accumulated Retained Earnings (Deficit) | -1.01B | ||
| Accumulated Other Comprehensive Income | -13.00K | ||
| Shareholders Equity | 374.13M | ||
| Shareholders Equity (USD) | 374.13M | ||
| Assets Non-Current | 26.11M | ||
| Total Debt (USD) | 20.67M | ||
| Liabilities Non-Current | 18.48M | ||
| Trade and Non-Trade Payables | 5.56M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.02M | ||
| Net Cash Flow from Financing | 239.03M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 236.56M | ||
| Capital Expenditure | -165.00K | ||
| Issuance (Purchase) of Equity Shares | 239.03M | ||
| Net Cash Flow from Investing | 44.76M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 44.92M | ||
| Net Cash Flow from Operations | -47.23M | ||
| Share Based Compensation | 5.15M | ||